Nazik Hammad: So proud of Haimanot Kasahun, a symbol of the rising local talent of oncologists in Africa

Nazik Hammad shared a post by OncoDaily on LinkedIn, adding:

“So proud of Haimanot Kasahun, a symbol of the rising local talent of oncologists in Africa.

The future belongs to you and your colleagues as you change cancer care in Africa to be more equitable, sustainable and inclusive.

This week, Dr. Haimanot Kasahun won this prestigious award, The Yvonne Award 2024 by OncoDaily, she is also a recipient of the ASCO IDEA Award American Society of Clinical Oncology (ASCO). She has earned it.

Just to give you a testimony, as the new lead of AORTIC– Africa medical oncology SIG; she and colleagues Mohammed Ezzi and others including Peter Oriyo, Omar Abdihamid conducted a 90 minute med onc AORTIC webinar yesterday discussing 2 cases of metastatic HER-2 positive breast cancer in young people (a 33 year old woman from Ethiopia and a 46 year old man from Ghana) and their cancer journeys with either no access to anti-HER 2 therapy or limited access.

Vigrous discussion on access, equity, policy and biology of disease in Africa including the unique experience of African patients and oncologists with zolidronic acid in bone mets! ; what is the right schedule? Are zolesronic acid generics sold in Africa working?

Real world issues led by the upcoming cadre in Africa. Happy to be a discussant and learner. Even happier to say as the previous lead for the med onc SIG, that our mentees are confidently taking things to the next level. Congratulations Haimanot Kasahun.”

Quoting OncoDaily’s post:

“Congratulations to Haimanot Kasahun Alemu for winning the Yvonne Award 2024 in the ‘Global Oncology’ category!

Your exceptional contributions and commitment have greatly advanced the field of global oncology.

The award will be handed out on May 31st at 8:30 pm in Chicago, IL, USA, during the OncoDaily Party.

P.S. If you haven’t received your party invitation yet, please check your mailbox first. If it’s not there, don’t forget to write to us.”

Proceed to video attached to the post.
Source: Nazik Hammad/LinkedIn and OncoDaily/LinkedIn

Nazik Hammad is a Sudanese Canadian Professor of medical oncology, at Saint Michael Hospital, Department of Medicine,  University of Toronto .  Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMIC) particularly in sub-Saharan Africa. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology,  women as health care professionals and cancer in conflict zones. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the Lancet Commission on Women, Power and Cancer.

Nazik Hammad is a Professor at the Division of Hematology and Oncology, St. Michael’s Hospital, University of Toronto. She is the Chair of the Education and Training Committee of the African Organization for Research and Training in Cancer (AORTIC). Dr. Hammad is a visiting professor at the University of Nairobi, Kenya. She is the co-chair of the Network for Advancing Black Learners (Medical Students and Residents) in Ontario. She is the former Director of Global Health at the Faculty of Health Sciences at Queen’s University. Dr. Hammad is the recipient 2019 Harvard Global Health Catalyst Distinguished Young Leader Award.